![Yi Shan Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Shan Li
Oprichter bij
BLOSSOMHILL THERAPEUTICS, INC.
Profiel
Yi Shan Li is the founder of Blossomhill Therapeutics, Inc., founded in 2020, holding the title of Executive Chairman since 2020.
Dr. Li was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title Head-TP Therapeutics Asia in 2019.
Former jobs include Director at SABiosciences Corp.
from 2002 to 2009, Executive Vice President at Epitomics, Inc. from 2008 to 2013, Member at the University of California, Berkeley, Principal at RBC Capital Markets LLC, Vice President at Kenson Ventures LLC from 2001 to 2003, and Principal at Santa Cruz Biotechnology, Inc. Education history includes a doctorate from The Ohio State University in 1994, an undergraduate degree from the University of Science & Technology of China in 1987, and an MBA from Haas School of Business in 2001.
Actieve functies van Yi Shan Li
| Bedrijven | Functie | Begin |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Oprichter | 01-06-2020 |
Eerdere bekende functies van Yi Shan Li
| Bedrijven | Functie | Einde |
|---|---|---|
| TURG POIN | Algemeen Directeur | 01-09-2018 |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Corporate Officer/Principal | 30-04-2013 |
SABiosciences Corp.
 SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Directeur/Bestuurslid | 31-12-2009 |
Kenson Ventures LLC
 Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Private Equity Investor | 31-12-2003 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Opleiding van Yi Shan Li
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
92
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kenson Ventures LLC
Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Finance |
Santa Cruz Biotechnology, Inc.
 Santa Cruz Biotechnology, Inc. BiotechnologyHealth Technology Provides primary antibodies and support products services | Health Technology |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SABiosciences Corp.
SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
